Richard Andrew Krasuski: documented history and research

About

Richard Andrew Krasuski | Duke Department of Medicine Living in the Era of the Fontan: Failure Should Simply Not be an Option - Professional Heart Daily | American Heart Association

ABLATION OF INTRA-ATRIAL REENTRANT TACHYCARDIA WITHIN THE LATERAL TUNNEL IN A PATIENT WITH FONTAN CIRCULATION

ASO 522 award from St. Jude Medical Inc.

Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension: Statement From the BPA-CTEPH Alliance

Beyond Body Mass Index: Skeletal Muscle Mass as a Marker of Physiologic Reserve in Fontan Circulation

Bile Acids, Mitochondria, and Myocardial Stiffness: A Shared Mechanism in Fontan Circulation and Metabolic Dysfunction-Associated Steatotic Liver Disease

Challenges and Growing experience in Heart Transplantation in Adult Congenital Heart Disease

Coauthored the commentary Living in the Era of the Fontan: Failure Should Simply Not be an Option

Congestive Heart Failure Device award from VoluMetrix, LLC

Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial

Impact of left ventricular assist device implantation on right ventricular-pulmonary arterial coupling assessed by high-fidelity hemodynamics

Insmed TPIP award from Insmed

Occluflex award from Occlutech US LLC

OVATION award from Actelion Pharmaceutical US, Inc.

Peer Coaching Adaptive Self-Management Interventions for Young Adults with Congenital Heart Disease award from the Adult Congenital Heart Association

Published over 350 peer-reviewed articles, book chapters, and meeting abstracts over his career

Reported receiving research funding from Actelion and Edwards Lifesciences in a 2019 disclosure

Richard Andrew Krasuski is a Duke cardiologist recognized by the university as a thought leader in pulmonary hypertension and congenital heart disease. He is an adjunct professor of medicine and pediatrics at Duke University Medical Center, where his research includes epidemiologic and clinical studies, multicenter ACHD research, research databases, and the EPIPHANY Study. His earlier leadership included directing the ACHD program at Cleveland Clinic from 2005 to 2015, as well as Duke’s Adult Congenital Heart Center, Hemodynamic Research, and CTEPH Program. He earned an M.D. from Harvard Medical School in 1994, completed internal medicine residency at Brigham and Women’s Hospital from 1994 to 1997, and cardiology fellowship at Duke from 1997 to 2001. He has mentored more than 100 trainees and published over 350 works.

Survey of Board-Certified Adult Congenital Heart Disease Providers Assessing Workforce Gaps

Trends and Projections for Aortic Stenosis and Hypertension-Related Mortality Among Older Adults in the United States: A Retrospective Population-Based Analysis

Trends in Tetralogy of Fallot-Related Mortality in the United States Between 1999 and 2020

Research interests

Described by Duke as a thought leader in pulmonary hypertension and congenital heart diseaseCo-PI in the EPIPHANY StudyHelped develop multiple research databases for pulmonary hypertension and congenital heart disease populationsInvolved in multiple multicenter studies through the Alliance for Adult Research in Congenital CardiologyResearch focus on epidemiologic and clinical studies involving pulmonary hypertension and congenital heart disease

Each topic is linked to its supporting source in Sources.

Training

Training includes Let’s Talk About the Fontan, Living Life Fully with Pulmonary Arterial Hypertension (PAH), The Complexities of Managing Pulmonary Hypertension in Congenital Heart Disease, and Pulmonary Arterial Hypertension (PAH): What’s New?, plus 20 more records.

Explore education and training